Clinical
Board and Executive Consultancies (since 2006)
Bei Biotechnologies Ltd (2006-2009),
Ohio State University (2009 - 2010),
Bionest Partners SARL (2010-2011),
PHI Vietnam Holdings Inc (2010-2013),
Regeneus Ltd (2010-2013),
Agenix Ltd (2011),
PharmAust Ltd (2013-2017),
Immuron Ltd (2015),
QEDDI (2023),
Mucpharm Pty Ltd (2023)
Neurizon Ltd (2024-2025),
ImmunoPDT Pty Ltd (2025) and
various nascent biotech startups (ongoing)